COMP <GO>
ALKS vs PRAX // DIVIDEND YIELD & FCF PAYOUT SAFETY
Alkermes plc (NASDAQ) VS. Praxis Precision Medicines Inc. (NASDAQ) • 15-METRIC TALLY: ALKS 6
— PRAX 3
■ METRIC PARITY
LAST: $45.37 (+0.27%) • MKT CAP: $7.61B
dividend-safety
0.00%
LAST: $288.62 (+1.10%) • MKT CAP: $8.06B
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALKS VS. PRAX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ALKS | PRAX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 86.70% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.00% | -35.00% | +49.00 | ALKS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 25.1x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 6.31% | -3.09% | +9.40 | ALKS | /fcf-yield <GO> |
| Operating Margin | 17.20% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 16.40% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -5.20% | 8.80% | -14.00 | PRAX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.03 | 26.00 | -17.97 | PRAX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 5/9 | +2.00 | ALKS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.3 | 56.3 | +5.00 | ALKS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 0.91 | +0.14 | ALKS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 29.3x | 33.0x | -3.70 | ALKS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.61B | $8.06B | -$446.8M | PRAX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ALKS REV | PRAX REV | ALKS GROSS % | PRAX GROSS % | ALKS FCF | PRAX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.48B | $0 | 86.7% | — | $480.3M | -$249.1M |
| FY 2024 | $1.56B | $8.6M | 84.2% | — | $405.6M | -$131.8M |
| FY 2023 | $1.66B | $2.4M | — | — | $326.5M | -$111.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALKS // BETA 1.05
PRAX // BETA 0.91